NCT07120646

Brief Summary

Children living beyond cancer (CBC) represent a unique and growing population of young people in need of long-term clinical support. Studies suggest that 11-44% of CBC experience chronic pain, negatively impacting a wide range of child biopsychosocial outcomes and creating high financial burden for their families and society. Often comorbid with pain, one of the most chronic and disturbing side effects reported by CBC are sleep disturbances, and in particular, difficulties initiating and maintaining sleep. Indeed, \>50% of CBC report some form of sleep disturbance even 9 to 15 years after the cancer diagnosis. Much attention has been paid to sleep and pain as independent constructs within pediatric oncology, yet Belgian data is lacking. Additionally, little is known about how these domains interact with one another and subsequent indications for prevention and intervention. Although evidence shows an interrelationship between pain and sleep in adult and pediatric populations, this interrelationship is understudied in childhood cancer patients and CBC. (Chronic) pain may serve as a modifiable target for interventions to improve sleep quality and vice versa, and understanding this relationship is crucial for providing comprehensive care to CBC. Therefore, this cross-sectional case-control study aims to explore the differences in pain and sleep disturbances in CBC compared to healthy age- and sex-matched healthy controls, as well as the interrelationship between both outcomes.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Aug 2025Jun 2026

First Submitted

Initial submission to the registry

June 26, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 13, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

10 months

First QC Date

June 26, 2025

Last Update Submit

August 11, 2025

Conditions

Keywords

children living beyond cancerpainsleep disturbancescase-control

Outcome Measures

Primary Outcomes (2)

  • Activity limitations due to pain

    Measured with the Child Activity Limitations Interview (CALI) - 9 (parent-report version for the 6-7 year-olds; self-report version for the 8-12 year-olds)

    Baseline about the past 14 days + 14 days following baseline in daily sleep diary

  • Sleep disturbances

    Assessed with the PROMIS Parent Proxy Item Bank v1.0 - Sleep Disturbance - Short Form 8a parent-report for the 6-7 year olds and PROMIS Pediatric Item Bank v1.0 - Sleep Disturbance - Short Form 8a for the 8-12 year-olds. Additionally, this outcome measure is assessed with the Children's Sleep Habits Questionnaire (CSHQ) (parent-report for all ages).

    Baseline

Secondary Outcomes (13)

  • Pain severity

    Baseline

  • Pain coping

    Baseline

  • Pain reporting and assessment during follow-up care

    Baseline

  • Health-related quality of life

    Baseline

  • Fatigue

    Baseline

  • +8 more secondary outcomes

Other Outcomes (1)

  • Information about prior night's sleep pattern and day

    From baseline to 14 days later

Study Arms (2)

children living beyond cancer (CBC)

Other: Questionnaire, actigraphy measurement and sleep diary

healthy controls

age- and sex-matched healthy controls

Other: Questionnaire, actigraphy measurement and sleep diary

Interventions

Baseline questionnaires (measuring socio-demographic and health-related information, as well as most outcome measures), followed by 2 weeks of actigraphy measurement and daily sleep diary.

children living beyond cancer (CBC)healthy controls

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children living beyond cancer (6-12 years old) and age- and sex-matched healthy controls, together with one of their parents.

You may qualify if:

  • CBC: 1) current age 6-12yo; 2) history of any cancer diagnosis; 3) ≤ 5y post- treatment completion; 4) ≥ 3 months since last cancer treatment (since pain and insomnia during treatment can be directly related to therapy and recover spontaneously); 5) fluent Dutch speaker and reader (age-dependent)
  • Healthy controls (age- and sex-matched): 1) current age 6-12yo; 2) no history of cancer ; 3) fluent Dutch speaker and reader (age-dependent)
  • Parents: 1) fluent Dutch speaker and reader

You may not qualify if:

  • CBC: 1) receiving palliative therapy; 2) psychiatric disorder; 3) severe intellectual disability
  • Healthy controls: 1) history of cancer; 2) psychiatric disorder; 3) severe intellectual disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vrije Universiteit Brussel

Jette, Brussels Capital, 1090, Belgium

Location

MeSH Terms

Conditions

PainParasomnias

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Emma Rheel, PhD

    Vrije Universiteit Brussel

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Emma Rheel, PhD

CONTACT

Nijs Jo, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

June 26, 2025

First Posted

August 13, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

August 13, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Data will be documented both at the project level and at the data level: Data level: * In research papers; * Information about variables using labels and variables derivations Project level * Documentation about the authors, background, aims, objectives, and the hypotheses that shape the research * Data collection protocol \& procedures * Project meeting reports Descriptive metadata of data items will be registered in Pure Database with restricted acces (closed access, only on reasonable request). In addition, the raw dataset will include labels in the .xlsx file including variable information providing documentation at the data level. Datasets will be accompanied by a separate word.doc file providing study-level documentation including the field methods used for data collection.

Time Frame
Within one year following the end of the study, for 10 years.
Access Criteria
Closed access (only on reasonable request)
More information

Locations